Connor, Clark & Lunn Investment Management Ltd.
Position in ROIV — Roivant Sciences Ltd.
CIK 1596800
VANCOUVER, A1
Position in ROIV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$994,919
-$2,931,821 QoQ
Shares Held
28,113
-92.5% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#238
of 494 holders
Holding Since
Jun 2023
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Connor, Clark & Lunn Investment Management Ltd. holds $650,455,383 across 105 Biotechnology names. ROIV ranks #64 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
135,236 | $67,175,777 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
684,236 | $54,253,072 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
625,569 | $50,990,129 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
420,063 | $49,176,775 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
42,465 | $26,478,625 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
97,698 | $23,913,539 | |
| 7 | INSM |
INSMED Inc
|
212,676 | $22,675,515 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
530,607 | $20,698,979 |
All Filings in ROIV
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $994,919 | 28,113 | Shares | Sole | 2026-08-13 | |
| 2024-03-31 | $3,926,740 | 372,556 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $10,095,388 | 898,966 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $9,098,311 | 778,965 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,367,069 | 135,622 | Shares | Sole | 2023-08-10 | |
| No filing history on record for this holder in this stock. | ||||||